Aller au contenu principal
Accès ouvert déclaré 2023 article

Cancer care at the time of the fourth industrial revolution: an insight to healthcare professionals’ perspectives on cancer care and artificial intelligence

33Citations signalées, ce qui n’est pas une note de qualité
9Institutions déclarées
7Pays d’affiliation déclarés

Rattachement africain : gb, fi, cy, gr, es, it, rs. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

BACKGROUND: The integration of Artificial Intelligence (AI) technology in cancer care has gained unprecedented global attention over the past few decades. This has impacted the way that cancer care is practiced and delivered across settings. The purpose of this study was to explore the perspectives and experiences of healthcare professionals (HCPs) on cancer treatment and the need for AI. This study is a part of the INCISIVE European Union H2020 project's development of user requirements, which aims to fully explore the potential of AI-based cancer imaging technologies. METHODS: A mixed-methods research design was employed. HCPs participating in cancer care in the UK, Greece, Italy, Spain, Cyprus, and Serbia were first surveyed anonymously online. Twenty-seven HCPs then participated in semi-structured interviews. Appropriate statistical method was adopted to report the survey results by using SPSS. The interviews were audio recorded, verbatim transcribed, and then thematically analysed supported by NVIVO. RESULTS: The survey drew responses from 95 HCPs. The occurrence of diagnostic delay was reported by 56% (n = 28/50) for breast cancer, 64% (n = 27/42) for lung cancer, 76% (n = 34/45) for colorectal cancer and 42% (n = 16/38) for prostate cancer. A proportion of participants reported the occurrence of false positives in the accuracy of the current imaging techniques used: 64% (n = 32/50) reported this for breast cancer, 60% (n = 25/42) for lung cancer, 51% (n = 23/45) for colorectal cancer and 45% (n = 17/38) for prostate cancer. All participants agreed that the use of technology would enhance the care pathway for cancer patients. Despite the positive perspectives toward AI, certain limitations were also recorded. The majority (73%) of respondents (n = 69/95) reported they had never utilised technology in the care pathway which necessitates the need for education and training in the qualitative finding; compared to 27% (n = 26/95) who had and were still using it. Most, 89% of respondents (n = 85/95) said they would be opened to providing AI-based services in the future to improve medical imaging for cancer care. Interviews with HCPs revealed lack of widespread preparedness for AI in oncology, several barriers to introducing AI, and a need for education and training. Provision of AI training, increasing public awareness of AI, using evidence-based technology, and developing AI based interventions that will not replace HCPs were some of the recommendations. CONCLUSION: HCPs reported favourable opinions of AI-based cancer imaging technologies and noted a number of care pathway concerns where AI can be useful. For the future design and execution of the INCISIVE project and other comparable AI-based projects, the characteristics and recommendations offered in the current research can serve as a reference.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Cancer care at the time of the fourth industrial revolution: an insight to healthcare professionals’ perspectives on cancer care and artificial intelligence
Date Crossref
09/10/2023
Éditeur
Springer Science and Business Media LLC
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Où se fait cette recherche

  • Kingston University London pays non établi dans la notice
    Université ou école supérieure
  • University of Turku pays non établi dans la notice
    Université ou école supérieure
  • Cyprus University of Technology pays non établi dans la notice
    Université ou école supérieure
  • International Hellenic University pays non établi dans la notice
    Université ou école supérieure
  • Aristotle University of Thessaloniki pays non établi dans la notice
    Université ou école supérieure
  • Hospital Clínic de Barcelona Urology Department pays non établi dans la notice
    Établissement de santé
  • University of Naples Federico II Department of Advanced Biomedical Science pays non établi dans la notice
    Université ou école supérieure
  • University of Novi Sad pays non établi dans la notice
    Université ou école supérieure
  • Oncology Institute of Vojvodina pays non établi dans la notice
    Structure de recherche
  • School of Life Sciences pays non établi dans la notice
    Université ou école supérieure
  • Faculty of Medicine Department of Radiology pays non établi dans la notice
    Université ou école supérieure
  • Oncology Institute of Vojvodine Diagnostic Imaging Center pays non établi dans la notice
    Structure de recherche

Kingston University London, University of Turku et Cyprus University of Technology, avec 9 autres affiliations.

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Artificial Intelligence in Healthcare and EducationAI in cancer detectionRadiomics and Machine Learning in Medical Imaging

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.